Ex Vivo and In Vivo Adenovirus-Mediated Gene Therapy Strategies Induce a Systemic Anti-Tumor Immune Defence in the B16 Melanoma Model
- 1 June 1998
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 110 (6) , 867-871
- https://doi.org/10.1046/j.1523-1747.1998.00221.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Adenoviral-Mediated Herpes Simplex Virus-Thymidine Kinase Gene Transfer in Vivo for Treatment of Experimental Human MelanomaJournal of Investigative Dermatology, 1996
- Effects of Gamma Irradiation on the Transduction of Dividing and Nondividing Cells in Brain and Muscle of Rats by Adeno-Associated Virus VectorsHuman Gene Therapy, 1996
- IL-12 Gene Therapy Using Direct Injection of Tumors with Genetically Engineered Autologous Fibroblasts. University of Pittsburgh, Pittsburgh, PennsylvaniaHuman Gene Therapy, 1995
- Current therapy for cutaneous melanomaJournal of the American Academy of Dermatology, 1995
- Paracrine Cytokine Adjuvants in Cancer ImmunotherapyAnnual Review of Immunology, 1995
- Inhibition of Melanoma Growth by Adenoviral-Mediated HSV Thymidine Kinase Gene Transfer In VivoJournal of Investigative Dermatology, 1995
- Targeted therapy for malignant melanomaCurrent Opinion in Oncology, 1994
- The Basic Science of Gene TherapyScience, 1993
- Anti‐metastatic vaccination of tumor‐bearing mice with il‐2‐gene‐inserted tumor cellsInternational Journal of Cancer, 1993
- Widespread long-term gene transfer to mouse skeletal muscles and heart.Journal of Clinical Investigation, 1992